You are here: Welcome to the MPKB » Welcome to the MPKB » Resources for patients » Length of the Marshall Protocol
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

home:patients:mp_duration [09.01.2019] – [After completion of the Marshall Protocol] sallieqhome:patients:mp_duration [09.14.2022] (current) – external edit 127.0.0.1
Line 23: Line 23:
 ==== Similarity of the MP to anti-tuberculosis treatments ==== ==== Similarity of the MP to anti-tuberculosis treatments ====
  
-The range of time it takes seriously ill patients to recover on the MP is not entirely without precedent in medicine.  The preferred regimen for the treatment of latent tuberculosis infection is 9 months of isoniazid.(({{pubmed>long:15941808}})) By contrast, that is only a single genus as opposed to a [[home:pathogenesis:microbiota|metagenomic microbiota]]. Note that both treatments are intended to kill intracellular pathogens. It's also worth noting that recovery from tuberculosis also involves an immunopathological-type reaction.(({{pubmed>long:18600241}}))+The range of time it takes seriously ill patients to recover on the MP is not entirely without precedent in medicine.  The preferred regimen for the treatment of latent tuberculosis infection is 9 months of isoniazid.(({{pmid>long:15941808}})) By contrast, that is only a single genus as opposed to a [[home:pathogenesis:microbiota|metagenomic microbiota]]. Note that both treatments are intended to kill intracellular pathogens. It's also worth noting that recovery from tuberculosis also involves an immunopathological-type reaction.(({{pmid>long:18600241}}))
  
 ===== Factors influencing length of treatment ===== ===== Factors influencing length of treatment =====
Line 96: Line 96:
 {{tag>Starting_the_Marshall_Protocol resource}} {{tag>Starting_the_Marshall_Protocol resource}}
  
 +<nodisp>
 ===== Notes and comments ===== ===== Notes and comments =====
    
Line 101: Line 102:
  
   * Legacy content   * Legacy content
-    * [[http://www.marshallprotocol.com/view_topic.php?id=1263&forum_id=32&jump_to=36589#p36589]] f16 +    * [[https://www.marshallprotocol.com/view_topic.php?id=1263&forum_id=32&jump_to=36589#p36589]] f16 
-    * [[http://www.marshallprotocol.com/forum32/1085.html#p42269]] f181 +    * [[https://www.marshallprotocol.com/forum32/1085.html#p42269]] f181 
-    * [[http://www.marshallprotocol.com/view_topic.php?id=1085&forum_id=32&jump_to=52849#p52849]] f182  +    * [[https://www.marshallprotocol.com/view_topic.php?id=1085&forum_id=32&jump_to=52849#p52849]] f182  
-    * [[http://www.marshallprotocol.com/forum32/1304.html]] f342  +    * [[https://www.marshallprotocol.com/forum32/1304.html]] f342  
-    * [[http://www.marshallprotocol.com/view_topic.php?id=1085&forum_id=32&jump_to=73778#p73778]] f185  +    * [[https://www.marshallprotocol.com/view_topic.php?id=1085&forum_id=32&jump_to=73778#p73778]] f185  
-    * [[http://www.marshallprotocol.com/view_topic.php?id=1085&forum_id=32&jump_to=81100#p81100]] f186  +    * [[https://www.marshallprotocol.com/view_topic.php?id=1085&forum_id=32&jump_to=81100#p81100]] f186  
-    * [[http://www.marshallprotocol.com/view_topic.php?id=1085&forum_id=32&jump_to=85306#p85306]] f187  +    * [[https://www.marshallprotocol.com/view_topic.php?id=1085&forum_id=32&jump_to=85306#p85306]] f187  
-    * [[http://www.marshallprotocol.com/forum32/2495.html#p33642]] f226+    * [[https://www.marshallprotocol.com/forum32/2495.html#p33642]] f226
        
  
  
-===== References =====+===== References =====</nodisp> 
home/patients/mp_duration.1567373440.txt.gz · Last modified: 09.01.2019 by sallieq
© 2015, Autoimmunity Research Foundation. All Rights Reserved.